Strategies for preventing peritoneal fibrosis in peritoneal dialysis patients: new insights based on peritoneal inflammation and angiogenesis
10.1007/s11684-017-0571-2
- Author:
Zhang ZHEN
1
;
Jiang NA
;
Ni ZHAOHUI
Author Information
1. Department of Nephrology
- Keywords:
peritoneal dialysis;
peritoneal fibrosis;
inflammation;
angiogenesis
- From:
Frontiers of Medicine
2017;11(3):349-358
- CountryChina
- Language:Chinese
-
Abstract:
Peritoneal dialysis (PD) is an established form of renal replacement therapy.Long-term PD leads to morphologic and functional changes to the peritoneal membrane (PM),which is defined as peritoneal fibrosis,a known cause of loss of peritoneal ultrafiltration capacity.Inflammation and angiogenesis are key events during the pathogenesis of peritoneal fibrosis.This review discusses the pathophysiology of peritoneal fibrosis and recent research progress on key fibrogenic molecular mechanisms in peritoneal infiammation and angiogenesis,including Toll-like receptor ligand-mediated,NOD-like receptor protein 3/interleukin-1β,vascular endothelial growth factor,and angiopoietin-2/Tie2 signaling pathways.Furthermore,novel strategies targeting peritoneal inflammation and angiogenesis to preserve the PM are discussed in depth.
